Advertisement

Journal of Public Health Policy

, Volume 32, Issue 3, pp 305–319 | Cite as

An analysis of China's national essential medicines policy

  • Xiaodong Guan
  • Huigang Liang
  • Yajiong Xue
  • Luwen Shi
Original Article

Abstract

Although China embraced the concept of essential medicines in 1979 and issued its first National Essential Medicines List in 1982, until recently China has lacked a comprehensive national essential drug policy. In its most recent health-care reform (2009–2012), the Chinese government explicitly proposed the establishment of a national essential medicines system, and made it one of five top priorities in the coming years. We review the evolution of China's essential medicines policies, explain the importance of fully implementing the essential medicines policy, and analyze recent policy developments surrounding essential medicines.

Keywords

essential medicines China pharmaceutical policy health-care reform 

References

  1. World Health Organization. (2006) Essential Medicines for Reproductive Health. Geneva: UNFPA, pp. 3–4.Google Scholar
  2. World Health Organization. (1977) WHO Expert Committee on Specifications for Pharmaceutical Substances. Twenty-sixth report. Geneva: WHO Technical Report Series, No.614.Google Scholar
  3. World Health Organization. (2001) How to Develop and Implement a National Drug Policy, 2nd edn. Malta: World Health Organization, p. 7.Google Scholar
  4. The Central Committee of the Communist Party of China and the State Council. (2009) Opinions on deepening the health care system reform, issued on 17 March 2009.Google Scholar
  5. The State Council of China. (2009) Implementation plan for the recent priorities of the health care system reform (2009–2011). Issued on 7 April 2009.Google Scholar
  6. Zhang, Z. and Shen, A. (2004) Comparative analysis of list of medicines in basic medical insurance and list of basic medicines. Chinese Health Service Management 191 (5): 317–318.Google Scholar
  7. Xiao, A. and Jing, C. (2005) A probe into the adjustment principle of national essential medicines list. Chinese Journal of Pharmacoepidemiology 14 (5): 300–302.Google Scholar
  8. World Health Organization. (2001) How to Develop and Implement a National Drug Policy, 2nd edn. Malta: World Health Organization, p. 6.Google Scholar
  9. China National Health Economics Institute. (2009) China National Health Accounts Report 2009. Beijing, People's Republic of China: China National Health Economics Institute.Google Scholar
  10. China Price Association and Peking University. (2007) Research on the Problem of Shortage of Inexpensive Medicines. Beijing, People's Republic of China: China Price Association and Peking University.Google Scholar
  11. China State Food and Drug Administration. (2010) Annual bulletin 2009, http://www.sda.gov.cn/WS01/CL0108/54601.html, accessed 10 June 2010.
  12. Cameron, A., Ewen, M., Ross-Degnon, D., Ball, D. and Laing, R. (2009) Medicine prices, availability, and affordability in 36 developing and middle-income countries: A secondary analysis. The Lancet 373: 240–249.CrossRefGoogle Scholar
  13. China State Food and Drug Administration. (2007) Notice on the First Batch of the List of Urban Communities and Rural Areas for the Fixed Manufacturing Enterprises and Types of Fixed-Point Production of Essential Medicines. GSYJA; No.76, 2007.Google Scholar
  14. Liang, H., Ding, J. and Xue, Y. (2011) China’s drug innovation and policy environment. Drug Discovery Today 16 (1–2): 1–3.CrossRefGoogle Scholar
  15. China State Food and Drug Administration. (2009) Medicines database, http://app1.sfda.gov.cn/datasearch/face3/dir.html, accessed 10 December 2009.
  16. China State Food and Drug Administration. (2009) 2009 National Drug Quality Announcement. Beijing: China State Food and Drug Administration.Google Scholar
  17. China State Food and Drug Administration. (2010) Medicines good manufacturing practice draft 2010, http://www.sda.gov.cn/WS01/CL0055/43997.html, accessed 10 January 2010.
  18. Wagstaff, A., Yip, W., Lindelow, A. and William, C.H. (2009) China's health system and its reform: A review of recent studies. Health Economics 18: S7–S23.CrossRefGoogle Scholar
  19. Eggleston, K., Li, L., Meng, Q., Lindelow, M. and Wagstaff, A. (2008) Health service delivery in China: A literature review. Health Economics 17: 149–165.CrossRefGoogle Scholar
  20. Li, Q. and Zeng, F. (2003) Urgency of the establishment of national medicines policy and its recommendations. Pharmacoepidemiology 12 (6): 282.Google Scholar
  21. Lucy, R. and Martin, M. (2009) Factors influencing antibiotic prescribing in China: An exploratory analysis. Health Policy 90: 32–36.CrossRefGoogle Scholar
  22. Tang, J. (2002) Current status of China's irrational use of medicines and countermeasures. Journal of Pediatrics 40 (8): 449–450.Google Scholar
  23. MOH. (2009) National essential medicines list (primary care section) 2009 edition, http://www.moh.gov.cn/publicfiles/business/htmlfiles/mohywzc/s3580/200908/42506.html, accessed 16 February 2011.
  24. Zhang, F. (2007) National Free AIDS Antivirals Manual, 2nd edn. Beijing: People's Medical Publishing House, pp. 33–38.Google Scholar
  25. Meng, R., Yang, B. and Ding, L.M. (2010) Analysis on the situation of abundant drugs versus few categories involved in essential drug list in China. China Pharmacy 21 (20): 1850–1851.Google Scholar
  26. China Ministry of Health. (2010) China Health Statistics Yearbook. Beijing: China Ministry of Health, pp. 268–306.Google Scholar
  27. Sun, Q., Santoro, M.A., Meng, Q., Liu, C. and Eggleston, K. (2008) Pharmaceutical policy in China. Health Affairs 27 (4): 1042–1050.CrossRefGoogle Scholar
  28. China National Development and Reform Commission. (2009) Notice of the State Development and Reform Commission concerning the Publishing of Guiding Retail Prices of National Essential Medicines. FGJG, No.2489.Google Scholar
  29. China Price Association. (2007) Collection of Current Prices of Medicines Regulated by the Government. Beijing, People's Republic of China: China Price Association.Google Scholar
  30. China Ministry of Human Resources and Social Security. (2009) Government Work Report Press Release. 13 April, Beijing.Google Scholar
  31. Shi, X. (2004) Procurement of medicines by centralized bidding from the trade point of view. China Pharmacy 15 (1): 7.Google Scholar
  32. Liang, H. and Xue, Y. (2004) Investigating public health emergency response information system initiatives in China. International Journal of Medical Informatics 73 (9–10): 675–685.CrossRefGoogle Scholar
  33. China National Development and Reform Commission. (2010) Answer Standing Committee of the National People's Congress Press Release. 24 December, Beijing.Google Scholar

Copyright information

© Palgrave Macmillan, a division of Macmillan Publishers Ltd 2011

Authors and Affiliations

  • Xiaodong Guan
    • 1
  • Huigang Liang
    • 2
  • Yajiong Xue
    • 2
  • Luwen Shi
    • 3
  1. 1.Department of Pharmacy Administration and Clinical PharmacyPeking UniversityBeijingChina
  2. 2.Center for Health Management Systems, College of Business, East Carolina UniversityGreenvilleUSA
  3. 3.International Research Center of Medicinal Administration, Peking UniversityBeijingChina

Personalised recommendations